Key result
Maternal HbA1c ≥6% during pregnancy was associated with increased large for gestational age infants, neonatal hypoglycemia, and visible birth defects.
Why the study?
High maternal HbA1c levels have been linked to increased risk of adverse neonatal outcomes, but the relationship between maternal HbA1c and neonatal outcomes warranted investigation.
Does elevated maternal HbA1c (≥6%) increase the risk of adverse neonatal outcomes in pregnant diabetic women?
Observational (n=94)
No
Does elevated maternal HbA1c (≥6%) increase the risk of adverse neonatal outcomes in pregnant diabetic women?
Elevated maternal HbA1c (≥6%) during pregnancy in diabetic women is a predictor for large for gestational age infants, neonatal hypoglycemia, and birth defects.
Answers are grounded in this paper and cite their sources.
Supports HbA1c monitoring in diabetic pregnancies; leaves open causality and optimal targets for prospective trials.
Background: HbA1c is now accepted as a standard measure for diagnosing type 2 diabetes mellitus. Maternal high HbA1c levels have been associated with increased risk of adverse neonatal outcomes. Objective: To find out the relationship between maternal HbA1c and neonatal outcomes. Materials & Methods: This prospective observational study was conducted from February 2018 to January 2019 in the Department of Neonatology and Department of Gynecology & Obstetrics, BSMMU, Dhaka. Diabetic mothers with known HbA1c Value and their infants who were born in this study period in BSMMU were enrolled. Neonates were divided into two groups. One group that had maternal HbA1c <6% and the other group >6%. Neonatal weights, routine capillary blood glucose were recorded. Results: Among the total 94 mothers, HbA1c level were <6% in 56 mothers and ³6% in 38 mothers. The mean weight, BMI and previous history of gestational diabetes of mothers were significantly higher in HbA1c ³6% group. Birth weight and large for gestational age infants was high in ³6% HbA1c group. Neonatal hypoglycemia developed more in high HbA1c group. Total visible birth defect was 4 and all were in high HbA1c group (p=0.022). Conclusion: Elevated HbA1c level during pregnancy is a predictor for large for gestational age infants as well as neonatal hypoglycemia. BANGLADESH J CHILD HEALTH 2021; VOL 45 (2) : 74-78
No takes yet. Share an insight, caveat, or question.
Saha et al. (2022) conducted an observational in Diabetic pregnancy (n=94). Maternal HbA1c ≥6% vs. Maternal HbA1c <6% was evaluated on Neonatal outcomes (birth weight, hypoglycemia, birth defects) (p=0.022). Maternal HbA1c ≥6% during pregnancy was associated with increased large for gestational age infants, neonatal hypoglycemia, and visible birth defects.
Synapse has enriched 10 related papers. Consider them for comparative context: